← back to search

Jia-Qin Hu

Guangzhou University of Chinese Medicine · CN
Area of research
Rheumatology · Immunology
Research interest
Research focused on Rheumatoid arthritis and Bioavailability, with related work in Pharmacology, Cancer research, Glycolysis. Notable publications include 'Novel nano-drug delivery system for natural products and their application', 'Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways', and 'Liver X receptor inverse agonist SR9243 attenuates rheumatoid arthritis via modulating glycolytic metabolism of macrophages'.
h-index
citations
297
works
9
NIH funding
primary concept
email

Recent publications

Suppressing ferroptosis via modulating FTH1 by silybin for treatment of renal fibrosis
Phytomedicine 2025cited by 5position: firstdoi
Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine
Cancers 2025cited by 1position: middledoi
Tangeretin formulated in a self-nano-emulsifying drug-delivery system (SNEDDS) alleviates symptoms of rheumatoid arthritis by antagonizing M1 macrophages polarization
Phytomedicine 2025cited by 0position: middledoi
Novel nano-drug delivery system for natural products and their application
Pharmacological Research 2024cited by 192position: middledoi
Liver X receptor inverse agonist SR9243 attenuates rheumatoid arthritis via modulating glycolytic metabolism of macrophages
Acta Pharmacologica Sinica 2024cited by 19position: middledoi
Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming
Pharmacological Research 2024cited by 10position: firstdoi
ShaShen-MaiDong decoction attenuates bleomycin-induced pulmonary fibrosis by inhibiting TGF-β/smad3, AKT/MAPK, and YAP/TAZ pathways
Journal of Ethnopharmacology 2024cited by 8position: middledoi
Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways
Acta Pharmacologica Sinica 2023cited by 52position: middledoi
Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment
Biomedicine & Pharmacotherapy 2023cited by 10position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ying Xie · Hebei Medical University8 papers (2023–2025)Hua Zhou · Guangzhou University of Chinese Medicine5 papers (2023–2025)Li Huang · Central South University3 papers (2024–2024)De-Chong Zheng · Guangzhou University of Chinese Medicine3 papers (2024–2025)Cang-Qiong Ning · Guangzhou University of Chinese Medicine2 papers (2024–2025)Jian Zhou · Fudan University2 papers (2025–2025)Chu-Tian Mai · Guangzhou University of Chinese Medicine2 papers (2024–2025)Nan Wang · Guangzhou University of Chinese Medicine2 papers (2025–2025)Peiyu Yan · Guangzhou University of Chinese Medicine2 papers (2024–2024)Lili Yu · Southern Medical University2 papers (2024–2024)Hua-Xue Huang · Macau University of Science and Technology1 papers (2024–2024)Jian Zhou · Fudan University1 papers (2024–2024)F Pi · Guangzhou University of Chinese Medicine1 papers (2025–2025)Peixun Wang · Guangzhou University of Chinese Medicine1 papers (2023–2023)Biao Qu · Anhui Medical University1 papers (2025–2025)Xi Yang · Macau University of Science and Technology1 papers (2024–2024)Li Huang · Guangxi University1 papers (2024–2024)Yan Dong · Guangzhou University of Chinese Medicine1 papers (2023–2023)Qian Li · Guangzhou University of Chinese Medicine1 papers (2025–2025)Xuehua Huang · Macau University of Science and Technology1 papers (2024–2024)